Mayana Zatz: Two critical questions take center stage – Which variants mitigate the impact of lethal mutations in severe conditions with mild phenotype? What factors contribute to the health and longevity of centenarians?
Genomic Psychiatry · 2024
DOI: 10.61373/gp024k.0016 ↗Abstract
Mayana Zatz has been a Professor of Genetics at the Institute of Biosciences, University of São Paulo (USP), Brazil, since 1982. She became an assistant professor after a postdoc at the University of São Paulo and a second postdoc at the University of California, Los Angeles. Her current research is focused on neuromuscular disorders, aging, genomics, and, more recently, xenotransplantation and the use of the Zika virus as an oncolytic therapy against brain tumors. Functional studies are done in genetically engineered mouse and cell models. She is particularly interested in investigating protective mechanisms in rare patients with Duchenne dystrophy and a milder clinical course, as well as in centenarians' health determinants. Mayana Zatz is also involved in ethical aspects of genomic studies and government political decisions related to science. Professor Zatz is pleased to offer our readers insights into her personal and professional experiences.
EUVIMED